In our study, we constructed FoxP3 in vivo and in vitro experiments, and we demonstrated that the expression level of FoxP3 in ccRCC was increased by the induction of BAP1 and SETD2 mutation. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.